158 related articles for article (PubMed ID: 2316816)
1. Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
Kanerva L
Am J Dermatopathol; 1990 Feb; 12(1):51-62. PubMed ID: 2316816
[TBL] [Abstract][Full Text] [Related]
2. Circular and branched Birbeck granules and cytomembrane blebbing in Langerhans' cells after dithranol irritation.
Kanerva L
Acta Derm Venereol; 1989; 69(5):407-9. PubMed ID: 2572106
[TBL] [Abstract][Full Text] [Related]
3. Electron microscopic observations of dyskeratosis, apoptosis, colloid bodies and fibrillar degeneration after skin irritation with dithranol.
Kanerva L
J Cutan Pathol; 1990 Feb; 17(1):37-44. PubMed ID: 2319038
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
5. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
[TBL] [Abstract][Full Text] [Related]
6. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream.
Swinkels OQ; Prins M; Gerritsen MJ; van Vlijmen-Willems IM; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):393-400. PubMed ID: 12476013
[TBL] [Abstract][Full Text] [Related]
8. Unusual mitochondrial reaction in psoriatic keratinocytes.
Klug H; Schulze P
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(3):201-3. PubMed ID: 2906191
[TBL] [Abstract][Full Text] [Related]
9. The effect of anthralin (dithranol) on mitochondria.
Morlière P; Dubertret L; Sa e Melo T; Salet C; Fosse M; Santus R
Br J Dermatol; 1985 May; 112(5):509-15. PubMed ID: 4005152
[TBL] [Abstract][Full Text] [Related]
10. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
[TBL] [Abstract][Full Text] [Related]
11. Skin susceptibility to dithranol: contact allergy or irritation?
Loffler H; Effendy I; Happle R
Eur J Dermatol; 1999; 9(1):32-4. PubMed ID: 9920984
[TBL] [Abstract][Full Text] [Related]
12. Electron microscopy of epidermal and dermal Langerhans' cells in long-lasting allergy patch tests.
Kanerva L
Arch Dermatol Res; 1989; 281(5):321-6. PubMed ID: 2802663
[TBL] [Abstract][Full Text] [Related]
13. The response of normal human skin to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Swinkels OQ; Prins M; Birker LW; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(4):262-9. PubMed ID: 12218288
[TBL] [Abstract][Full Text] [Related]
14. Irritant reactions to dithranol in normal subjects and psoriatic patients.
Kingston T; Marks R
Br J Dermatol; 1983 Mar; 108(3):307-13. PubMed ID: 6830696
[TBL] [Abstract][Full Text] [Related]
15. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
16. Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.
Benezeder T; Painsi C; Patra V; Dey S; Holcmann M; Lange-Asschenfeldt B; Sibilia M; Wolf P
Elife; 2020 Jun; 9():. PubMed ID: 32484435
[TBL] [Abstract][Full Text] [Related]
17. Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding.
de Zwart AJ; de Jong EM; van de Kerkhof PC
Skin Pharmacol; 1992; 5(1):34-40. PubMed ID: 1374264
[TBL] [Abstract][Full Text] [Related]
18. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
Brody I
Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
[TBL] [Abstract][Full Text] [Related]
19. [The irritant effect of dithranol using capillary resistance measurement].
Kemény L; Csató M; Nyirádi J; Gábor M; Dobozy A
Z Hautkr; 1989 Jan; 64(1):34-40. PubMed ID: 2522697
[TBL] [Abstract][Full Text] [Related]
20. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
